RAG-05

N/A

Report date: 2024/11/22 14:26:03
NME

Base Information

Drug NameRAG-05
Drug Alias NameRAG-05
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > small activating RNA
Mechanisms of ActionPorphobilinogen deaminase modulators
TargetsPorphobilinogen deaminase
Therapy Area/IndicationsPorphyria, Acute Intermittent
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesRactigen Therapeutics (Nantong) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesRactigen Therapeutics (Nantong) Co Ltd
Inactive CompaniesN/A
Active IndicationsPorphyria, Acute Intermittent
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A